from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0771/-

LFCtreatmentdescriptionclass of inhibitor

0.123

Amikacinug/mL Amikacintranslation

-0.082

Cap5-10ug/mL Capreomycintranslation

0.235

Rox10-50 ug/mL Roxithromycintranslation

0.573

SM2-5 ug/mL Streptomycintranslation

-1.289

Tet5-10 ug/mL Tetracyclinetranslation

-0.407

Rif0.2-5ug/mL Rifampicintranscription

-0.144

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.304

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.215

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.456

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.213

Clofazimine10-13 ug/mL Clofaziminerespiration

0.316

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-3.299

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.529

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.663

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.197

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.136

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.541

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.090

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.920

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.728

KCN5-20 ug/mL Potassium cyaniderespiration

0.631

NaN30.2-2 mM Sodium aziderespiration

0.592

Nigericin50 uM Nigericinrespiration

-0.377

TRC10-150 ug/mL Triclosanrespiration

-1.192

TRZ10-25 ug/mL Thioridazinerespiration

-0.553

Valinomycin0.5-10 uM Valinomycinrespiration

1.956

ZnSO42 mM ZnSO4respiration

0.926

menadione6-10 ug/mL Menadionerespiration

1.048

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.154

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.404

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.727

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.413

NRP_1Non-replicating persistence stage 1dosRassociated

-0.300

Amp0.2mg/mL AmpicillincellWall

0.125

Cephalexin20-100 ug/mL CephalexincellWall

0.606

Cerulenin0.32-5 ug/mL CerulenincellWall

0.097

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.425

EMB10-20 ug/mL EthambutolcellWall

0.162

Eta12-40 ug/mL EthionamidecellWall

-0.037

INH0.2-0.4 ug/mL IsoniazidcellWall

0.103

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.387

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.826

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.041

BZA0.12 mg/mL BenzamidearomaticAmides

0.370

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.335

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.468

H2O24 mM hydrogen peroxideDNAdamaging

0.322

Levo10 ug/mL LevofloxacinDNAdamaging

-0.023

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.057

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.505

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.612

UVUV-irradiationDNAdamaging

1.127

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.281

Antimycin12.5-50 ug/mL Antimycin A?

-0.185

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.128

PA_110-50 ug/mL Antitubercular compound PA-1?

0.300

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.307

PA8240.2-2 ug/mL PA-824?

-0.924

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.258

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.163

Verapamil50 uM Verapamil?

0.517

mercaptoethanol2 mM 2-Mercaptoethanol?

0.751

methoxatin10-20 ug/mL Methoxatin?